Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitazoxanide-based Regimens for Helicobacter Pylori
NCT02422706Phase 3Unknown
- Start
- Jan 2015
- Primary completion
- Dec 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of nitazoxanide in Helicobacter pylori infection. Status: unknown.
02
Drugs
nitazoxanide
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT02422706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02422706.